Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818321 · ClinicalTrials.gov registry record · Phase 2
Urinary Track Infection Prevention After Urogynecological Surgery
A Phase 2 study, sponsored by TriHealth.
- Completed
- Registry status
- Phase 2
- Development phase
- 185
- Enrollment target
NCT03818321 is a Phase 2 study that has completed, run by TriHealth. The registered enrollment target is 185 participants.
The verdict
NCT03818321, a Phase 2 study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 185 participants
- Enrollment target
Study Summary
This study is randomized double-blinded placebo-controlled trial to access oral Methenamine Hippurate (MH) in combination with cranberry capsules is superior to cranberry capsules alone in prevention of UTI in patients with transient post-operative urinary retention requiring a Foley catheter after pelvic reconstructive surgery.
Interventions
- DRUG Placebo tablet
- DRUG Methenamine Hippurate 1 g tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2019-06-17 |
| Est. Completion | 2021-07-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03818321
The ClinicalTrials.gov registry entry for NCT03818321 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo tablet is the first listed.
NCT03818321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03818321 about?
NCT03818321 is a clinical study titled "Urinary Track Infection Prevention After Urogynecological Surgery". This study is randomized double-blinded placebo-controlled trial to access oral Methenamine Hippurate (MH) in combination with cranberry capsules is superior to cranberry capsules alone in prevention of UTI in patients with transient post-operative urinary retention requiring a Foley catheter after ...
What is the current status of trial NCT03818321?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 185 participants. The study started on 2019-06-17. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03818321?
The interventions under investigation include: Placebo tablet (DRUG), Methenamine Hippurate 1 g tablet (DRUG).
Who is sponsoring clinical trial NCT03818321?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.